Answers are grounded in this paper and cite their sources.
In order to select the most appropriate treatment for patients with prostate cancer, it is critical to diagnose the disease burden accurately at initial diagnosis. In this study, we investigated a new diagnostic imaging agent in a large population of men with primary prostate cancer. We found it to have an excellent safety profile and to provide clinically useful information regarding the presence of disease beyond the prostate.
No takes yet. Share an insight, caveat, or question.
Surasi et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: